155 results on '"Coglianese, Erin"'
Search Results
2. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update
3. Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death
4. Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock
5. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy
6. Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory Death.
7. Persistent Iron Deficiency and Dysregulated Hepcidin Levels After Durable Left Ventricular Assist Device Therapy
8. Mechanical Support of the Failing Right Heart
9. Post-exercise Oxygen Uptake Recovery Delay In Individuals With Left Ventricular Assist Device
10. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
11. Mechanical Support of the Failing Right Heart
12. Abstract 16910: High-Frequency In-Person Visits During Clinical Trial Enrollment is Associated With Relative Reduction in Event Rates in Heart Failure Patients Followed Longitudinally
13. Proteomic Signatures During Treatment in Different Stages of Heart Failure
14. Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HVAD Using a Hybrid Intention to Treat Population
15. Effect Of Impella 5.5® On Pre-existing Functional Mitral Regurgitation In Patients With Heart Failure-associated Cardiogenic Shock
16. Case 37-2022: A 55-Year-Old Man with Fatigue, Weight Loss, and Pulmonary Nodules
17. Persistent Iron Deficiency and Dysregulated Hepcidin Levels After Durable Left Ventricular Assist Device Therapy
18. A Multicenter Study of Left Ventricular Assist Device-Related Gastrointestinal Bleeding
19. Abstract 18472: Hepcidin Dysregulation and Iron Deficiency Following Left Ventricular Assist Device Implantation
20. The Value of Psychosocial Factors in Patient Selection and Outcomes after Heart Transplantation
21. Clinical Monitoring of Stage B Heart Failure: Echocardiography
22. Usefulness of the Blood Hematocrit Level to Predict Development of Heart Failure in a Community
23. Reference Limits for N-Terminal-pro-B-Type Natriuretic Peptide in Healthy Individuals (from the Framingham Heart Study)
24. Markers of graft injury and the conundrum of racial disparities in outcomes after heart transplantation: early insights for long term outcomes.
25. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
26. Left Ventricular Assist Device Explant and Mitral Valve Replacement for Myocardial Recovery
27. 969 A MULTI-CENTER STUDY EVALUATING OVERT VS. OCCULT LEFT VENTRICULAR ASSIST DEVICE (LVAD)-RELATED BLEEDING
28. 968 A MULTI-CENTER STUDY OF LEFT VENTRICULAR ASSIST DEVICE (LVAD)-RELATED BLEEDING
29. PROTEOMIC CHARACTERIZATION OF STAGE C AND D HEART FAILURE: IDENTIFICATION OF A CORE PROTEIN SIGNATURE AND EFFECT OF TREATMENT
30. Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation
31. Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
32. Left Ventricular Assist Device Explant and Mitral Valve Replacement for Myocardial Recovery.
33. Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants
34. Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants
35. Down-Regulation of Protein C Pathway Associated with Increased Inflammation in Patients with Implanted Ventricular Assist Devices As a Potential Cause of Pump Thrombosis
36. Clinical and Hemostatic Characteristics of Patients With Ventricular Assist Device Thrombosis
37. Are Microparticle Levels Useful for Detecting Thrombosis in Patients with Ventricular Assist Devices?
38. Clinical Characteristics of Patients with Suspected Left Ventricular Assist Device Thrombosis Who Respond to Intensified Anticoagulation
39. Cellular Microparticles As Predictive Markers for Thrombosis and Other Clinical Events in Patients with Implanted Lvads
40. Inflammatory Cytokines Are Upregulated in Patients with Implanted Ventricular Assist Devices
41. Etiology and Timing of Readmissions After LVAD Implantation
42. Effects of Prolonged Postoperative Inotrope Administration after Left Ventricular Assist Device Implantation
43. Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study
44. 317 - Clinical and Hemostatic Characteristics of Patients With Ventricular Assist Device Thrombosis
45. Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
46. Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study
47. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
48. Testosterone Supplementation in Heart Failure
49. EFFECT OF TESTOSTERONE SUPPLEMENTATION ON EXERCISE CAPACITY IN HEART FAILURE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
50. Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.